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Objective: The objective of this study was to investigate the feasibility of arthroscopic airbrush assisted
cartilage repair.
Methods: An airbrush device (Baxter) was used to spray both human expanded osteoarthritic chon-
drocytes and choncrocytes with their pericellular matrix (chondrons) at 1  106 cells/ml ﬁbrin glue
(Tissucol, Baxter) in vitro. Depth-dependent cell viability was assessed for both methods with confocal
microscopy. Constructs were cultured for 21 days to assess matrix production. A controlled human
cadaveric study (n ¼ 8) was performed to test the feasibility of the procedure in which defects were ﬁlled
with either arthroscopic airbrushing or needle extrusion. All knees were subjected to 60 min of
continuous passive motion and scored on outline attachment and defect ﬁlling.
Results: Spraying both chondrocytes and chondrons in ﬁbrin glue resulted in a homogenous cell dis-
tribution throughout the scaffold. No difference in viability or matrix production between application
methods was found nor between chondrons and chondrocytes. The cadaveric study revealed that air-
brushing was highly feasible, and that defect ﬁlling through needle extrusion was more difﬁcult to
perform based on ﬁbrin glue adhesion and gravity-induced seepage. Defect outline and coverage scores
were consistently higher for extrusion, albeit not statistically signiﬁcant.
Conclusion: Both chondrons and chondrocytes can be evenly distributed in a sprayed ﬁbrin glue scaffold
without affecting viability while supporting matrix production. The airbrush technology is feasible, easier
to perform than needle extrusion and allows for reproducible arthroscopic ﬁlling of cartilage defects.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage defects are a known cause of disability in
young and active patients and treatment of these challenging in-
juries is becoming standard of care in orthopedic practice. Current
algorithms include microfracture for smaller defects and autolo-
gous chondrocyte implantation (ACI) or osteochondral autograft: D.B.F. Saris, Department of
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ternational. Published by Elsevier Ltransfer system (OATS) for larger defects (>2.5 cm2)1,2. ACI is
capable of stimulating hyaline-like tissue regeneration with good
clinical results up to 20 years3. Since ACI was ﬁrst introduced in the
early nineties, different generations have been developed to
improve structural and patient outcomes as well as surgical
handling4,5. Today, third generation ACI, which uses a collagen or
hyaluronic acid scaffold, is one of the most widely used cell-based
therapies in sports medicine. Although an arthroscopic approach
has been described, it is only performed in ‘expert hands’2,6. Again,
these treatments are successful in the mid to long-term follow-up
but require two surgical procedures and are expensive7. What's
more, the focus in regenerative medicine has primarily been on
optimizing cellular products, and not on improving surgical tech-
niques, creating a gap in translation of new technologies into
clinical practice. Consequently, surgeons mainly use atd. All rights reserved.
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manipulation of cell-laden (hydrogel) scaffolds and their subse-
quent ﬁxation remains a challenge8,9. In the last few years, focus
has gone from a two-stage to a single-stage procedure as this is of
less burden on the patient and could be more cost-effective in the
long term. For example, a recent study showed positive early clin-
ical and radiological outcome after carbon dioxide insufﬂated
arthroscopic microdrilling and collagen/ﬁbrin gel application for
large (2e8 cm2) defects10. In addition, single-stage procedures us-
ing stem cells are increasingly being introduced in clinical trials11,12.
Recently, we have completed the inclusion of a phase I/II clinical
trial (IMPACT trial, clinicaltrials.gov: NCT02037204, http://www.
youtube.com/watch?v¼S3rIBj A03AA) in which chondrons and
mesenchymal stromal cells (MSCs) are mixed in a ﬁbrin glue scaf-
fold and implanted within one surgical procedure. Gel-based
cellular therapies often require an open surgical procedure as the
slope of the femoral condyles create difﬁculty in keeping the
scaffold in place whilst gelating13. As it is known that arthroscopy is
less invasive and has a faster recovery time and shorter in-hospital
stay compared to an open procedure14, introducing an easy to
handle gel application system would be highly valuable. Our pro-
posed airbrush technology platform may allow for an arthroscopic
delivery of gel which immediately gelates and adheres to the sub-
chondral bone under any slope in any joint. Spray-applied cell
therapy has already found its way in other ﬁelds and for example,
was shown capable of healing venous leg ulcers in a recent ran-
domized controlled trial15. The purpose of this study was to
investigate the feasibility of spraying cell-based ﬁbrin glue scaffold
in an arthroscopic cadaver model.
Material and methods
Study outline
To evaluate the hypothesis that airbrushing does not affect cell
survival we conducted a laboratory study in which we performed a
viability assay to compare cell death after airbrushing and needle
injection (n ¼ 4). Using a glycosaminoglycan (GAG) assay, we
wanted to test whether the airbrush system would affect cartilage
regeneration in vitro. Once the in vitro study was ﬁnished, we
started a controlled laboratory study to investigate the surgical
feasibility of the arthroscopic airbrush approach in comparison to
needle extrusion.
Donors
Cartilage was obtained from redundant material from ﬁve pa-
tients undergoing total knee arthroplasty. The anonymous use and
collection of this material was performed according to the Medical
Ethical regulations of the UniversityMedical Center Utrecht and the
guideline ‘good use of redundant tissue for research’ of the Dutch
Federation of Medical Research Societies.
Cell isolation
Chondrocytes with their pericellular matrix (chondrons) were
acquired using a two hour rapid digestion protocol adapted from
Bekkers et al.16 Brieﬂy, the cartilagewas cut into small pieces, rinsed
in phosphate buffered saline (PBS) (Life technologies, UK) and
digested for two hours in 1% Collagenase type II (Worthington,
Lakewood New Jersey) at 37C in Dulbecco's modiﬁed Eagle's me-
dium (DMEM) (Life Technologies, Bleiswijk, the Netherlands) with
1% penicillin/streptomycin (100 U/mL/100 mg/mL; Invitrogen, Life
Technologies). After digestion, the suspension was ﬁltered through
a 100 mm cell strainer (BD Biosciences, San Diego, CA, USA), thechondrons were washed once in PBS, spun by centrifugation at
300 g in ten minutes and resuspended in 100 mL PBS. For compar-
ison, chondrocytes were isolated overnight using 0.15% Collagenase
type II (Worthington, Lakewood New Jersey) using the same me-
dium and washing procedure.
Preparation of the cell containing ﬁbrin glue
For the application of cells/chondrons, a commercially available,
clinical grade ﬁbrin glue (Tissucol Duo 500, Baxter) kit was used
which consists of a syringe containing a solution comprising
ﬁbrinogen, ﬁbronectin, plasminogen and factor XIII, and one con-
taining thrombin. After mixture, the components gelate immedi-
ately upon injection and gelation is complete after approximately
30 s. After isolation (Passage 0) cells were resuspended in the
ﬁbrinogen component at an overall concentration of 2  106 cells/
ml ﬁbrin glue and placed next to the thrombin syringe.
Airbrush and controls
For the airbrush application, the two-component system was
connected to a clinically approved airﬂow device (DuploSpray MIS,
Baxter) which regulates the outﬂow of compressed air (1 bar)
through sterile ﬁlters. The cell-laden ﬁbrin glue was sprayed at a
distance of approximately 2 cm in 24-well plates at a doses of
500 ml per well. As a control, 500 ml the ﬁbrin glue was extruded
through a needle into the well. Per donor, three samples were used
for each condition. After the cell-laden ﬁbrin constructs weremade,
1 ml of culture medium was added. Culture medium consisted of
DMEM supplemented with 2% insulin-transferrine-selenium (ITS)-
X (Invitrogen), 2% l-ascorbic acid-2-phospate (AsAp; Sigma-
eAldrich), 2% human serum albumin (HSA; Sanquin Blood Supply
Foundation Amsterdam, the Netherlands), 1% penicillin/strepto-
mycin (100 U/mL/100 mg/mL) and 1 ng/ml TGF-b2 (R&D Systems,
Minneapolis, Minnesota).
Assessment of cell viability
To evaluate the effect of spraying on cells, a viability assay using a
live/dead staining kit for mammalian cells (Molecular Probes,
Eugene, OR, USA) was performed according to the manufacturer's
instruction after application. The ﬁbrin hydrogel constructs were
washed 3 timeswith DMEMand transferred to amicroscopy slide to
be visualizedwith a ﬂuorescencemicroscope. Live (green) and dead
cells (red) were counted by two observers (TdW and JB) indepen-
dently. If there was a discrepancy in scoring, a consensus was
reached. To test the hypothesis that cells impacted on the solid
surface would be less viable (depth dependent viability), both
chondrons and chondrocytes (n¼ 4)were sprayed (two samples per
condition) into a six well chamber slide (Lab-Tek, Nalge Nunc In-
ternational), subjected to a viability assay and observed using laser
scanning confocal microscopy with a construct height (Z) of up to
2600mm. Leica TCS SP5 inverted confocalmicroscope equippedwith
a HCX PL APO CS 63/1.20-0.60 OIL objective (Leica Microsystems,
The Netherlands). During visualization, dyes were excited simulta-
neouslywith a 488-nm argon laser and detected using two separate
photomultipliers set to appropriate bandwidths. Slides were
bundled and divided in quartiles. The cell distribution and viability
was compared between the lower and upper quartile.
Cell culture and glycosaminoglycan analysis
Chondron laden ﬁbrin glue was sprayed (n ¼ 4) or extruded
(n ¼ 4) and cultured for 21 days (two samples per donor). The
culture medium was changed twice a week. After the 3-week
Table I
Modiﬁed macroscopic scoring system
Outline attachment* Area coveragey
100% (5) Unchanged (100%) (5)
75e100% (4) 75e100% (4)
50e75% (3) 50e75% (3)
25e50% (2) 25e50% (2)
0e25% (1) <25% (1)
0% (0) 0% (0)
* % of full circumference that has contact with the surrounding
cartilage rim.
y % of total cartilage defect that is covered by ﬁbrin glue.
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digestion buffer (250 mg/ml papain (SigmaeAldrich), 0.2 M
NaH2PO4, 0.1M EDTA, 0.01M cysteine) prior to quantiﬁcation of the
GAG content with a dimethylmethylene blue (DMMB) assay with
an absorption ratio of 540 nme595 and chondroitin-6-sulphate
(SigmaeAldrich) as a standard. DNA content in the papain digests
was determined using a Picogreen DNA assay (Invitrogen) accord-
ing to the manufacturer's instruction.
Cadaveric study
To test the surgical feasibility of the arthroscopic airbrush sys-
tem, a controlled human cadaveric study was performed in eight
different knee joints of six male and two female donors (age range
56e88) in accordance with the guidelines of the local ethical
committee. The specimens were derived from bodies who entered
the Department of Anatomy through a donation program. From
these persons, written informed consent was obtained during their
lifetime that allowed use of their bodies for educational and
research purposes. Each knee was tested on (visual) malalignment,
stability and range of motion (full extension and at least 80
ﬂexion). A mini-arthrotomy of approximately 5 cm was performed
using a medial parapatellar approach to obtain a view of the medial
femoral condyle while preventing leakage of synovial ﬂuid. A
template was used with a diameter of 1.6 cm (square surface
2.0 cm2) to create standard sized full-thickness cartilage defects.
Using a sharp spoon, the defect was debrided and the calciﬁed layer
removed. The knee was closed in layers prior to performing a car-
bon dioxide (CO2) insufﬂated arthroscopy (Smith&Nephew)with a
standard anterolateral approach. The two-component holder of the
cell laden (2  106 cells/ml) ﬁbrin glue was connected to the
DuploSpray system which was originally designed to spray a ﬁbrin
sealant as a hemostatic agent for laparoscopic surgery17,18. For the
cadaveric study, both chondrons (n ¼ 3) and chondrocytes (n ¼ 5)
were used. The ﬁbrin glue was stained with Fast Green FCF (Merck
Millipore, Darmstadt, Germany) and randomly applied to the
cartilage defect, using either the airbrush system (n ¼ 4), or a
standard Duplotip syringe (Baxter) (n ¼ 4) utilizing CO2 insufﬂa-
tion. Afterwards, each leg was subjected to a continuous passive
motion (CPM) protocol19,20. Brieﬂy, the legs were ﬁrmly strapped
onto a CPMmachine (Medical sot B.V., Losser, the Netherlands) and
subjected to 60 cycles of full extension to 80 degree ﬂexion in one
hour. After the CPM protocol, the knees were reopened and pho-
tographed for macroscopic analysis. Next, the ﬁbrin glue was
thoroughly removed from the defect site, the knee closed in layers
and the same cartilage defect was used for arthroscopic application
of the alternative treatment followed by the CPM and evaluation
protocol. The knees were scored by four independent observers
(blinded for the application method) using a modiﬁed macroscopic
scoring system adapted from previous work (Table I)19,20. To assess
the reliability of the macroscopic scoring system, inter-observer
agreement was determined as well as testeretest analysis (intra-
observer agreement) with a 2-month interval.
Cryomicrotome sectioning
To assess the defect ﬁll and the local dispersion of the cell laden
ﬁbrin glue after the arthroscopic airbrush procedure two random
specimens were used for cryomicrotome sectioning. In short, the
specimens were frozen overnight, followed by embedding en block
in 1% carboxymethylcellulose (CMC) at 25C for 24 h. Cry-
osections were obtained using a cryomicrotome (CM3600 XP; Leica
Biosystems, Nussloch, Germany) with a 50 mm interval. The sections
weremade in a in a transverse plane for one specimen and a frontal
plane for the other. Each section was photographed (Leica DFC450 C, Leica the Netherlands) and photographs were bundled for
evaluation.
Statistical analysis
Interdependent Samples t-tests were used to compare the
viability and matrix production between the extrusion and
airbrush method. To determine both the inter-rater and the intra-
rater (testeretest) agreement for the macroscopic scoring of the
extrusion and airbrush application, the mean (FleisseCohen)
weighted Κ was used21e23. A Κ value of <0.20 was considered to
indicate slight agreement, 0.21e0.40 fair agreement, 0.41e0.60
moderate agreement, 0.61e0.80 substantial agreement and
0.81e0.99 almost perfect agreement24. For the inter-rater agree-
ment, the outline and coverage scores were compared between all
observers and mean Κ values were determined along with the
standard deviation. Similarly, testeretest scores were determined
for each individual observer and Κ values were averaged. Chi-
square analysis was conducted to compare the macroscopic
scores between both application methods per individual rater. For
the statistical analysis, Excel 2007 (Microsoft) and SPSS version 20
(IBM SPSS Inc. Chicago, Illinois) were used.
Results
Assessment of cell viability
Airbrush applied scaffolds could be centralized and contained
within the wells of the 24 well plate without cells leaving the ﬁbrin
glue as conﬁrmed by microscopy. The mean cell viability of chon-
drons for the airbrush group was 76.7% (conﬁdence interval (CI)
[66.6, 86.7]) and 73.8% (CI [62.4, 85.3]) for the extrusion group
(P¼ 0.69) (Fig. 1) Confocal microscopy showed an even distribution
of live and dead cells through the sprayed ﬁbrin construct and no
difference in viability between cells impacting on the solid surface
(lower quartile viability 88.4% (CI [78.1, 92.7])) and the cells in the
superﬁcial layer of the ﬁbrin construct (upper quartile viability
85.1% (CI [76.7, 93.6])) P ¼ 0.87 (Fig. 2). When chondrons were
replaced by chondrocytes, confocal microscopy demonstrated
comparable overall cell viability results with an average cell
viability for airbrush of 80.8% (CI [69.9, 91.7]) and 78.8% (CI [67.9,
89.8]) for extrusion P ¼ 0.83. When comparing the viability after
spraying between chondrons (76.7% (CI) [66.6, 86.7]) and chon-
drocytes (80.8% (CI [69.9, 91.7])) no statistically signiﬁcant differ-
ence was found P ¼ 0.66.
Cell culture and glycosaminoglycan analysis
The airbrush system did not affect the capability of cultured
chondrocytes to produce GAGs as the average produced GAG per
DNAwas 1.19 (CI [0.33, 2.04]) after spraying and 0.59 (CI [0.11, 1.08])
Fig. 3. Glycosaminoglycan (GAG) per DNA (average and 95% conﬁdence interval) for
the 21-day ﬁbrin glue cultures (n ¼ 4). Comparison between airbrush and extrusion.
Fig. 1. Cell viability (average % and 95% conﬁdence interval) for the airbrush and
extrusion application (n ¼ 4).
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statistically signiﬁcant (P ¼ 0.28) (Fig. 3).
Cadaveric study
Arthroscopic airbrushing was found to be a feasible surgical
procedure which was easy to perform and allowed for a local de-
livery with containment in the defect. Arthroscopic needle extru-
sion was more challenging to perform as gravity induced seepage
and unintentional adhesion of the construct to the needle disturbed
surgical ease. No difference in gross appearance or gelation time
was observed when chondrons or chondrocytes were used. For the
four observers, the average outline and coverage score for theFig. 2. Confocal microscopy after the airbrush application of chondron laden ﬁbrin glue (n ¼
and superﬁcial layer. Green and red staining indicated live and dead cells, respectively.airbrushmethod was 4.25 (CI [3.84, 4.66]) and 4.31 (CI [3.98, 4.65]),
respectively. The average outline and coverage score for extrusion
was 4.13 (CI [3.65, 4.60]) and 3.84 (CI [3.09, 4.60]), respectively
[Fig. 4(A) and (B)]. Figure 5 provides pictures of the best and worst
results in terms of defect ﬁll for both application methods. For
needle extrusion the worst case demonstrates a half empty defect
which was a result of part of the construct adhering to the needle.
Although the macroscopic scores were slightly higher for air-
brushing, especially for the coverage scores, chi-square analysis
showed that differences between both application methods were
not signiﬁcant (P range 0.20e1.00). The inter-rater agreement was
good (mean Κ > 0.70) for the macroscopic outline score and
moderate to excellent (mean Κ range 0.54e0.88) for the coverage
score (Table II). Similarly, the intra-rater (testeretest) reliability was
good for the outline scores (mean Κ > 0.70) and moderate to good4). A homogenous distribution was found with an equal survival in the lower, central
Fig. 4. A, Modiﬁed macroscopic outline score (average and 95% conﬁdence interval)
for the different observers (n ¼ 8 specimens). B, Modiﬁed macroscopic coverage
score (average and 95% conﬁdence interval) for the different observers (n ¼ 8
specimens).
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cryomicrotome analysis showed a complete ﬁll of the defect
without migration of the graft (Supplemental Movie 1 and 2).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.joca.2014.09.016.
Discussion
The most important ﬁnding of the present study is that
arthroscopic cell therapy using an airbrush system does not affect
cellular viability and has good surgical feasibility. Compared to
direct needle extrusion, airbrushing was found to have superior
surgical handling, good defect ﬁll and similar outline and coverage
scores. Needle extrusion was surgically unpractical due to gravity
induced seepage and unintentional adhesion to the needle
[Fig. 5(D)].
The rapid advancements in regenerative medicine have not yet
led to a cartilage repair method with easy arthroscopic handling5.
Spray-applied cell therapy has gained more attention in recent
years, as it is easy to use, allows for fast gelation, good adherence
and local cellular regeneration25. In their randomized controlled
trial Kirsner et al.15 demonstrated an added value of using cells
(keratinocytes and ﬁbroblasts) in a spray applied ﬁbrin glue for the
treatment of chronic venous leg ulcers. Two separate studies
showed that a cell-laden ﬁbrin spray can safely and effectively be
delivered to (burn) wounds26,27. Using the same airbrush system as
in the present study, adipose derivedMSCs were also demonstrated
to be capable of forming endothelial tubules in vitro realizing an
easy to handle approach for vascular and dermal regeneration25.
Surprisingly, none of the above-mentioned studies provided
viability data, which in terms of scientiﬁc validation, is of great
importance for such cellular therapies. Thus to the best of our
knowledge, the present study is the ﬁrst to demonstrate that the
viability of cells is not affected by spraying in a ﬁbrin carrier. Fibringlue is a scaffold known for its regenerative capacity for cartilage,
bone and dermal regeneration28e30. Despite the fact that it is
widely used, and has been proven to be safe and effective in vivo, it
may be that hydrogels which have a slower degradation process
could further improve implant stability13,31,32. For example, pho-
topolymerizable PEG hydrogels have shown up to 10-times stron-
ger adhesion to articular cartilage in comparison to ﬁbrin glue33,34.
A hydrogel suitable for a (arthroscopic) spray application needs
both immediate gelation upon the aerosol mixing state and good
adherence. It thus may well be that biomechanically improved
hydrogels with self-attaching and cell-attracting properties are
equally suitable for an airbrush application35. Perhaps more
importantly, the proposed airbrush system can serve as a platform
for further development of an easy to handle approach for larger
cartilage defects using an optimal hydrogel. Other arthroscopic
(single-stage) gel-based procedures may also beneﬁt from an
airbrush application as the slope of the femoral condyle and gravity
create difﬁculty when inserting hydrogels. For instance, the surgical
handling of the collagen/ﬁbrin gel covered microfracture as
recently introduced by Shetty et al.10 could be improved by using an
airbrush system. However, thismicrofracture techniquemay be less
suitable for larger defects, as they may respond better to osteo-
chondral autologous transfer or cell therapy36,37.
There are some critical remarks to be made regarding the pre-
sent study. Although we did not ﬁnd an effect of airbrushing on
viability and matrix production, we cannot rule out other (subtle)
cellular responses airbrushing has on cells. For example, it is known
that increased (hydrostatic) pressure can inﬂuence matrix gene
expression of expanded chondrocytes38e40. However, it should be
mentioned that these studies used pressures ranging from 5 to 100
Bar where we have used an air pressure of only 1 bar. Indeed, it
could be that viability is affected only at higher pressures, such as
previously shown for bioprinting, or that ﬁbrin glue provides pro-
tection upon impaction41. Moreover, the ﬁnding that chondrocytes
show reversible pressure-induced cytoskeletal remodeling could
suggest there may only be a temporary response to spraying which
we have not observed42. It may be valuable to investigate the effect
spraying has on cells on a more detailed level to determine optimal
spray conditions.
In the present study, chondrons were used for the proposed
cellular therapy. Chondrons are chondrocytes with their peri-
cellular matrix which have been shown to have a better capability
of cell-induced cartilage production compared to chondrocytes
both in vitro and in a small animal model16,43e45. The fact that
chondrons were found to bemechanically stiffer than chondrocytes
could mean that chondrons are better suitable to undergo
increased pressure upon spraying46. Nevertheless, we did not
encounter a statistically signiﬁcant difference in confocal micro-
scopy evaluated depth-dependent survival between chondrons and
chondrocytes. Moreover, as a variety of cells were found capable of
inducing tissue regeneration after a spray application, it is likely
that different cell types can be used for spraying15,25e28,47,48.
As we have performed a cadaver study, we do not know the ef-
fects spraying ﬁbrin glue will have on integration with the native
tissue. Securing integration of cellular transplants is a known chal-
lenge that needs to be addressed33. Still, aswehave found both good
defect ﬁll and cellular distribution, we do not anticipate integration
would differ between sprayed and non-sprayed transplants.
In this study we have used a CPM model that is similar to our
non-weight bearing protocol immediately after surgery. It could be
however, that the (muscle) strain on the transplant is higher in vivo.
Nonetheless, cartilage tissue regeneration using ﬁbrin glue incor-
porated cell transplantation has been shown after immediate
weight bearing in animal models16,49 and standard (delayed)
weight bearing protocols in early clinical trials13,50.
Fig. 5. Pictures showing a full-thickness cartilage defect on the medial femur condyle in a human cadaveric knee with the best defect coverage and outline results after both
airbrushing (A) and needle extrusion (B). The worst results for both methods are shown in C and D.
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quires a CO2 insufﬂated arthroscopy. This is especially so when a
water-assisted concomitant procedure such as shaving is required.
Our pilot study has taught us that it is feasible to perform a water-
insufﬂated arthroscopy prior to utilizing CO2 insufﬂation, though
the defect needs to be blown dry before spraying. CO2 insufﬂation
was recently shown to be a safe technique capable of advancing
surgical comfort compared to traditional ﬂuid arthroscopy without
a higher risk of gas embolism51. The authors suggested that the use
of a pneumatic tourniquet avoids a potential systemic diffusion of
gas. The additional safety concerns regarding spray-applied cell
therapy in the knee are minimal. According to the Food and Drug
Administration (FDA), the occurrence of air embolisms (in nine
patients) was associated with laparoscopic application of spray-
applied sealants with higher than recommended pressures and
too close proximity52. From these patients, one received the sameTable II
Inter-rater and intra-rater agreement for the macroscopic outline and coverage score
Score Inter-rater reliability
Application n Κ CI
Outline Extrusion 8 0.79 0.72e0.
Outline Airbrush 8 0.71 0.58e08
Outline Overall 16 0.73 0.67e0.
Coverage Extrusion 8 0.88 0.84e0.
Coverage Airbrush 8 0.54 0.35e0.
Coverage Overall 16 0.82 0.76e0.
Inter-rater reliability was calculated as the mean agreement between the different obser
interval of 2 months.
n, number of specimens scored.
Κ, Kappa statistic.
CI, 95% conﬁdence interval.sealant as we have used in this study, and no clear relationship with
the procedure was found. What's more, the cellular spray applica-
tion on a minimally vascularized bony surface may better resemble
topical spray-applied cell therapy, which for venous ulcers and
burn wounds, has been shown to be safe without the occurrence of
embolisms15,26,27. Taken the above into account and considering a
local use in accordance with current guidelines (pressure 1 bar,
2 cm distance) and the (standard) use of a tourniquet, the risk of
using a cellular spray system is considered particularly low. Thus
the prospect of providing a surgeon with an extra tool during
standard as well as dry arthroscopic procedures further stimulates
the development of an airbrush platform for hydrogel-based
arthroscopic cartilage repair prior to (animal) testing and clinical
introduction, especially since using an inexpensive commercially
available spray-system will not have a negative effect on cost-
utilities. Here it is important to stress that this is anIntra-rater (testeretest) reliability
Application n Κ CI
86 Extrusion 8 0.72 0.58e0.85
3 Airbrush 8 0.70 0.55e0.86
80 Overall 16 0.71 0.63e0.78
91 Extrusion 8 0.76 0.61e0.91
74 Airbrush 8 0.55 0.45e0.65
87 Overall 16 0.66 0.53e0.79
vers and Intra-rater reliability as the mean agreement within each observer with an
T.S. de Windt et al. / Osteoarthritis and Cartilage 23 (2015) 143e150 149investigator-driven study that used a clinically available system to
allow fast clinical translation.
Although there were subtle differences in observer blinded
outline and outcome scores in favor of airbrushing, the cadaver
study may have been underpowered to show a statistical differ-
ence. This subtle difference found, was largely attributable to par-
tial delamination of the graft which was a result of adhesion to the
needle upon extrusion. [Fig. 5(D)] Indeed, although it could not be
quantiﬁed, our study showed that both in experienced and non-
experienced hands, airbrush assisted cell therapy was easier to
perform with a higher success rate in terms of defect coverage.
Conclusion
This is the ﬁrst study to show that both chondrons and chon-
drocytes can be evenly distributed in a sprayed ﬁbrin glue scaffold
without affecting cellular viability while supporting matrix pro-
duction. This stimulates further development of the airbrush sys-
tem for fast clinical translation and creates a platform for future
analysis using mechanically stronger hydrogels for articular carti-
lage repair.
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